Jitendra Mohan Sells 94,971 Shares of Astera Labs (NASDAQ:ALAB) Stock

Astera Labs, Inc. (NASDAQ:ALABGet Free Report) CEO Jitendra Mohan sold 94,971 shares of the company’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the completion of the sale, the chief executive officer directly owned 1,452,739 shares of the company’s stock, valued at $179,863,615.59. The trade was a 6.14% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Astera Labs Stock Up 2.3%

Astera Labs stock traded up $3.04 during trading hours on Thursday, hitting $132.62. 2,894,530 shares of the company traded hands, compared to its average volume of 5,941,660. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90. The firm has a market cap of $22.40 billion, a P/E ratio of 108.70, a P/E/G ratio of 2.55 and a beta of 1.50. The firm’s 50-day simple moving average is $160.78 and its two-hundred day simple moving average is $174.12.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. The company had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.87%. The business’s revenue for the quarter was up 91.8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, equities research analysts predict that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on ALAB shares. Morgan Stanley reaffirmed an “overweight” rating and set a $210.00 price target on shares of Astera Labs in a research note on Wednesday, December 3rd. Wall Street Zen cut Astera Labs from a “buy” rating to a “hold” rating in a research note on Tuesday, November 11th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Astera Labs in a report on Wednesday, January 21st. Barclays set a $165.00 price target on shares of Astera Labs in a report on Thursday, January 15th. Finally, TD Cowen reaffirmed a “hold” rating on shares of Astera Labs in a research note on Wednesday, November 5th. Fourteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $192.89.

Read Our Latest Stock Report on Astera Labs

Institutional Trading of Astera Labs

Several large investors have recently added to or reduced their stakes in ALAB. Vanguard Group Inc. raised its holdings in shares of Astera Labs by 29.6% during the 2nd quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock valued at $1,089,491,000 after purchasing an additional 2,751,747 shares in the last quarter. Atreides Management LP boosted its holdings in Astera Labs by 2,496.6% in the fourth quarter. Atreides Management LP now owns 1,611,194 shares of the company’s stock worth $268,038,000 after purchasing an additional 1,549,144 shares in the last quarter. Amundi increased its position in Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after buying an additional 1,319,643 shares during the last quarter. Rafferty Asset Management LLC bought a new position in Astera Labs during the third quarter valued at about $209,599,000. Finally, BNP Paribas Financial Markets lifted its position in shares of Astera Labs by 577.3% in the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after buying an additional 960,899 shares during the last quarter. 60.47% of the stock is owned by institutional investors.

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

See Also

Insider Buying and Selling by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.